DETERMINATION OF URAPIDIL HYDROCHLORIDE IN RABBIT PLASMA BY LC-MS-MS AND ITS APPLICATION TO A PHARMACOKINETIC STUDY

被引:25
作者
Ma, Jianshe [2 ]
Lin, Guanyang [1 ]
Wang, Xianchuan [3 ]
Li, Junwei [4 ]
Wang, Xianqin [4 ]
Hu, Lufeng [1 ]
机构
[1] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou 325035, Peoples R China
[2] Wenzhou Med Coll, Funct Expt Teaching Ctr, Wenzhou 325035, Peoples R China
[3] Wenzhou Med Coll, Network Informat Ctr, Wenzhou 325035, Peoples R China
[4] Wenzhou Med Coll, Analyt & Testing Ctr, Wenzhou 325035, Peoples R China
关键词
LC-MS-MS; pharmacokinetics; plasma; urapidil hydrochloride; LIQUID-CHROMATOGRAPHY; 5-HT1A RECEPTORS; HUMAN-SERUM; METABOLITES; EXTRACTION;
D O I
10.1080/10826076.2011.547413
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and selective liquid chromatography tandem mass spectrometry (LC-MS-MS) method for determination of urapidil hydrochloride in rabbit plasma was developed and validated. After addition of doxapram hydrochloride as the internal standard (IS), protein precipitation by 10% trichloroacetic acid was used as the sample preparation. Chromatographic separation was achieved on a Zorbax SB-C18 (2.1mmx50mm, 3.5m) column with acetonitrile-water as the mobile phase with gradient elution. Electrospray ionization (ESI) source was applied and operated in positive ion mode; multiple reaction monitoring (MRM) mode was used to quantification using target fragment ions m/z 387.9204.6 for urapidil hydrochloride and m/z 378.9291.8 for the IS. Calibration plots were linear over the range of 5-1000ng/mL for urapidil hydrochloride in plasma. Lower limit of quantitation (LLOQ) for urapidil hydrochloride was 5ng/mL. Mean recovery of urapidil hydrochloride from plasma was in the range 93.5%-96.4%. RSD of intra-day and inter-day precision were both less than 12%. This developed method is successfully used in pharmacokinetic study of urapidil hydrochloride in rabbit.
引用
收藏
页码:307 / 316
页数:10
相关论文
共 13 条
[1]   Determination of tropisetron in human plasma by liquid chromatography-tandem mass spectrometry [J].
Deng, Pan ;
Zhong, Dafang ;
Chen, Xiaoyan .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (03) :848-852
[2]   Urapidil - A reappraisal of its use in the management of hypertension [J].
Dooley, M ;
Goa, KL .
DRUGS, 1998, 56 (05) :929-955
[3]  
Hansson L, 1994, Blood Press Suppl, V4, P45
[4]  
Hansson L, 1995, Blood Press Suppl, V3, P21
[5]   Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies [J].
Hirschl, MM ;
Binder, M ;
Bur, A ;
Herkner, H ;
Mullner, M ;
Woisetschlager, C ;
Laggner, AN .
INTENSIVE CARE MEDICINE, 1997, 23 (08) :885-888
[6]   INVOLVEMENT OF BRAIN 5-HT1A RECEPTORS IN THE HYPOTENSIVE RESPONSE TO URAPIDIL [J].
KOLASSA, N ;
BELLER, KD ;
SANDERS, KH .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (07) :D7-D10
[7]   EVIDENCE FOR THE INTERACTION OF URAPIDIL WITH 5-HT1A RECEPTORS IN THE BRAIN LEADING TO A DECREASE IN BLOOD-PRESSURE [J].
KOLASSA, N ;
BELLER, KD ;
SANDERS, KH .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (06) :C36-C39
[8]   QUANTITATION OF URAPIDIL AND ITS METABOLITES IN HUMAN-SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
NIEDER, M ;
DILGER, C ;
HAERLIN, R .
JOURNAL OF HIGH RESOLUTION CHROMATOGRAPHY & CHROMATOGRAPHY COMMUNICATIONS, 1985, 8 (05) :224-229
[9]  
SCHOBER JG, 1984, EUR J PEDIATR, V43, P87
[10]   PHARMACOLOGIC PROFILE OF URAPIDIL [J].
VANZWIETEN, PA .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (07) :D1-D6